Singapore markets open in 4 hours 55 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,308.15 +61.47 (+1.17%) Dow
39,908.00 +349.89 (+0.88%) Nasdaq
16,742.39 +231.21 (+1.40%) Bitcoin USD
65,886.99 +4,313.02 (+7.00%) CMC Crypto 200
1,392.96 +125.01 (+9.86%)
PCVX May 2024 70.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:15PM EDT. Market open.
| Previous close | 1.4000 |
| Open | 1.2500 |
| Bid | 0.7500 |
| Ask | 4.6000 |
| Strike | 70.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.2500 - 1.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 258 |
- GuruFocus.com
Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview
Consistent with Analyst Projections Amidst Strategic Advancements
GlobeNewswireVaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program -- -- VAX-24 Infant Phase 2 Study Enrollment Completed; Topline Data from Primary Immunization Series Expected by End of First Quarter of 2025, Followed by Topline Data from Booster Dose by End of 2025 -- -- $1.9 Billion in Cash, Cash Equivalen
GuruFocus.comInsider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares
On May 1, 2024, Jim Wassil, the Chief Operating Officer of Vaxcyte Inc (NASDAQ:PCVX), sold 3,000 shares of the company.
© 2024 Yahoo. All rights reserved.